Technology

Welcome back to This Week in Apps, the weekly TechCrunch series that recaps the latest in mobile OS news, mobile applications and the overall app economy. The app economy in 2023 hit a few snags as consumer spending last year dropped for the first time by 2% to $167 billion, according to data.ai’s “State of […]

This Week in Apps: AI-powered productivity apps, US weighs TikTok ban, SVB crash boosts crypto apps by Sarah Perez originally published on TechCrunch

For many people around the world, braille is their primary language for reading books and articles, and digital braille readers are an important part of that. The newest and fanciest yet is the Monarch, a multipurpose device that uses the startup Dot’s tactile display technology. The Monarch is a collaboration between HumanWare and the American […]

The Monarch could be the next big thing in Braille by Devin Coldewey originally published on TechCrunch

The asymmetry in time and effort it takes human artists to produce original art vs the speed generative AI models can now get the task done is one of the reasons why Glaze, an academic research project out of the University of Chicago, looks so interesting. It’s just launched a free (non-commercial) app for artists […]

Glaze protects art from prying AIs by Natasha Lomas originally published on TechCrunch

It’s a very modern conjurer’s trick: Create an SXSW talk out of thin air, with the help of generative AI. That’s what whurley did this year in Austin. It took nine weeks for whurley — a staple of the Austin tech scene — to create and prepare for a keynote at SXSW 2018, where he […]

Strangeworks might be the first startup to rely on AI to create everything it brought to SXSW by Kirsten Korosec originally published on TechCrunch

With SVB’s contagion contained, the VC community seems open to writing smallish checks for pre-revenue startups.

TechCrunch+ roundup: 7 VCs who are taking pitches, AI best practices, zero-based budgeting by Walter Thompson originally published on TechCrunch

Regeneron Pharmaceuticals, a biotechnology company that develops life-transforming medicines, found itself inundated with vast volumes of data during the peak of the covid-19 pandemic. In order to derive actionable information from these disparate data sets, which ranged from clinical trial data to real-time supply chain information, the company needed new ways to join and relate…